[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01GA01, streptomycin, Opium may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[M03AB01, succinylcholine, The risk or severity of bradycardia can be increased when Succinylcholine is combined with Opium.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01CG01, sulbactam, Sulbactam may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Sulfamethoxazole may decrease the excretion rate of Opium which could result in a higher serum level.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Sulpiride is combined with Opium.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Sulthiame is combined with Opium.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Opium which could result in a higher serum level.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Opium.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Opium is combined with Temazepam.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Opium which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Dabigatran etexilate may decrease the excretion rate of Opium which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Opium which could result in a higher serum level.]
[N07XX06, tetrabenazine, The metabolism of Opium can be decreased when combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of adverse effects can be increased when Tetracaine is combined with Opium.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AE05, lurasidone, The risk or severity of adverse effects can be increased when Lurasidone is combined with Opium.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Apomorphine is combined with Opium.]
[L04AX02, thalidomide, Opium may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Opium.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Opium which could result in a higher serum level.]
[R06AD03, thiethylperazine, The risk or severity of hypotension and CNS depression can be increased when Thiethylperazine is combined with Opium.]
[N05CA19, thiopental, The risk or severity of adverse effects can be increased when Thiopental is combined with Opium.]
[N05AB08, thioproperazine, The risk or severity of hypotension and CNS depression can be increased when Thioproperazine is combined with Opium.]
[N05AC02, thioridazine, The metabolism of Opium can be decreased when combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Thiothixene is combined with Opium.]
[C01BB04, aprindine, The metabolism of Opium can be decreased when combined with Aprindine.]
[G04BE06, moxisylyte, Moxisylyte may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Opium is combined with Tiapride.]
[B01AC05, ticlopidine, The metabolism of Opium can be decreased when combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Opium is combined with Tilidine.]
[S01ED01, timolol, Timolol may decrease the excretion rate of Opium which could result in a higher serum level.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Opium which could result in a higher serum level.]
[S01AA12, tobramycin, Opium may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Opium which could result in a higher serum level.]
[V04CA01, tolbutamide, Tolbutamide may decrease the excretion rate of Opium which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Opium which could result in a higher serum level.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Tolperisone is combined with Opium.]
[N02AX02, tramadol, The risk or severity of serotonin syndrome can be increased when Opium is combined with Tramadol.]
[N06AF04, tranylcypromine, The risk or severity of adverse effects can be increased when Opium is combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Opium.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Opium is combined with Triazolam.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AB12, mepenzolate, The risk or severity of adverse effects can be increased when Mepenzolate is combined with Opium.]
[A16AX12, trientine, Triethylenetetramine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AB06, trifluoperazine, The risk or severity of hypotension and CNS depression can be increased when Trifluoperazine is combined with Opium.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Opium is combined with Trifluperidol.]
[N05AA05, triflupromazine, The risk or severity of adverse effects can be increased when Triflupromazine is combined with Opium.]
[N04AA01, trihexyphenidyl, The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Opium.]
[A03AA05, trimebutine, The risk or severity of adverse effects can be increased when Trimebutine is combined with Opium.]
[R06AD01, trimeprazine, The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Opium.]
[N03AC02, trimethadione, The risk or severity of adverse effects can be increased when Trimethadione is combined with Opium.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Trimethaphan is combined with Opium.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Opium.]
[R06AC04, tripelennamine, The metabolism of Opium can be decreased when combined with Tripelennamine.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Triprolidine is combined with Opium.]
[A03BB01, butylscopolamine, The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Opium.]
[J01FA08, troleandomycin, The metabolism of Opium can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Opium can be decreased when combined with Vilazodone.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Opium.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Tubocurarine is combined with Opium.]
[R03DX07, roflumilast, Roflumilast may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01FX04, ipilimumab, Ipilimumab may decrease the excretion rate of Opium which could result in a higher serum level.]
[R02AA14, oxyquinoline, Opium may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[L02BX03, abiraterone, The metabolism of Opium can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Opium can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Opium can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Opium can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Opium can be decreased when combined with Rilpivirine.]
[S01AA28, vancomycin, Opium may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Ezogabine is combined with Opium.]
[B01AF01, rivaroxaban, Rivaroxaban may decrease the excretion rate of Opium which could result in a higher serum level.]
[B01AC24, ticagrelor, Opium can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08DA01, verapamil, The metabolism of Opium can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Opium can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Opium can be decreased when combined with Vinblastine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Opium which could result in a higher serum level.]
[B01AA03, warfarin, Opium may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[S01AA13, fusidic acid, The metabolism of Opium can be decreased when combined with Fusidic acid.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AF05, zuclopenthixol, The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Opium.]
[J05AE02, indinavir, The metabolism of Opium can be decreased when combined with Indinavir.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Levetiracetam is combined with Opium.]
[L01EC01, vemurafenib, The metabolism of Opium can be decreased when combined with Vemurafenib.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Opium which could result in a higher serum level.]
[M05BA05, tiludronic acid, Tiludronic acid may decrease the excretion rate of Opium which could result in a higher serum level.]
[B06AC02, icatibant, Icatibant may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Opium can be decreased when combined with Crizotinib.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Opium is combined with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Deferiprone may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Ruxolitinib may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04BD07, tolterodine, The risk or severity of adverse effects can be increased when Tolterodine is combined with Opium.]
[J01DH04, doripenem, Doripenem may decrease the excretion rate of Opium which could result in a higher serum level.]
[C07AB03, atenolol, The metabolism of Opium can be decreased when combined with Atenolol.]
[J02AC03, voriconazole, The metabolism of Opium can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Atracurium is combined with Opium.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Opium which could result in a higher serum level.]
[B03XA04, peginesatide, Peginesatide may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Opium which could result in a higher serum level.]
[L04AX01, azathioprine, Azathioprine may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Opium which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Opium.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[A08AA11, lorcaserin, The metabolism of Opium can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Opium can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Opium can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Opium can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Opium can be decreased when it is combined with Enzalutamide.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Opium.]
[N05CA04, barbital, The risk or severity of adverse effects can be increased when Barbital is combined with Opium.]
[D02BA02, octinoxate, Octinoxate may decrease the excretion rate of Opium which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Opium can be decreased when combined with Nelfinavir.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[N04BD02, rasagiline, The risk or severity of adverse effects can be increased when Opium is combined with Rasagiline.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Opium is combined with Mosapride.]
[N06DA02, donepezil, The risk or severity of adverse effects can be increased when Donepezil is combined with Opium.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[N02CC03, zolmitriptan, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Opium.]
[R06AC06, thonzylamine, The risk or severity of adverse effects can be increased when Thonzylamine is combined with Opium.]
[G04BD10, darifenacin, The risk or severity of adverse effects can be increased when Darifenacin is combined with Opium.]
[V09IX04, fluorodeoxyglucose F18, Fludeoxyglucose (18F) may decrease the excretion rate of Opium which could result in a higher serum level.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Opium is combined with Diethyl ether.]
[G04BE03, sildenafil, The metabolism of Opium can be decreased when combined with Sildenafil.]
[V08CA11, gadofosveset, Gadofosveset trisodium may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Opium.]
[A16AX08, teduglutide, Teduglutide may decrease the excretion rate of Opium which could result in a higher serum level.]
[A10BH04, alogliptin, Alogliptin may decrease the excretion rate of Opium which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Opium can be decreased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Pomalidomide is combined with Opium.]
[G03XC05, ospemifene, The metabolism of Opium can be decreased when combined with Ospemifene.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Opium is combined with Benperidol.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AX06, tegaserod, The metabolism of Opium can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The risk or severity of adverse effects can be increased when Benzocaine is combined with Opium.]
[L03AA12, ancestim, Ancestim may decrease the excretion rate of Opium which could result in a higher serum level.]
[M01AH01, celecoxib, The metabolism of Opium can be decreased when combined with Celecoxib.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Naratriptan is combined with Opium.]
[L04AA18, everolimus, The metabolism of Opium can be decreased when combined with Everolimus.]
[N04AC01, benztropine, The risk or severity of adverse effects can be increased when Benzatropine is combined with Opium.]
[L01EC02, dabrafenib, The serum concentration of Opium can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01EE01, trametinib, Trametinib may decrease the excretion rate of Opium which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Opium.]
[V09AX05, florbetapir F-18, Florbetapir (18F) may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AX28, levomilnacipran, The risk or severity of serotonin syndrome can be increased when Opium is combined with Levomilnacipran.]
[C08EA02, bepridil, The metabolism of Opium can be decreased when combined with Bepridil.]
[A10BJ03, lixisenatide, Lixisenatide may decrease the excretion rate of Opium which could result in a higher serum level.]
[C02KX04, macitentan, Macitentan may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01EL01, ibrutinib, The metabolism of Opium can be decreased when combined with Ibrutinib.]
[N06AX26, vortioxetine, The risk or severity of adverse effects can be increased when Vortioxetine is combined with Opium.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Opium which could result in a higher serum level.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Opium is combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Opium can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, Sofosbuvir may decrease the excretion rate of Opium which could result in a higher serum level.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Vigabatrin is combined with Opium.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Droxidopa may decrease the excretion rate of Opium which could result in a higher serum level.]
[C07AB04, acebutolol, The metabolism of Opium can be decreased when combined with Acebutolol.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Tasimelteon is combined with Opium.]
[A16AA07, metreleptin, The metabolism of Opium can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Opium can be increased when combined with Apremilast.]
[L02BG02, formestane, Formestane may decrease the excretion rate of Opium which could result in a higher serum level.]
[S01ED02, betaxolol, The metabolism of Opium can be decreased when combined with Betaxolol.]
[V03AB34, fomepizole, Fomepizole may decrease the excretion rate of Opium which could result in a higher serum level.]
[L04AC11, siltuximab, The metabolism of Opium can be increased when combined with Siltuximab.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Opium is combined with Alfaxalone.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Opium which could result in a higher serum level.]
[D11AA01, glycopyrronium, The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Opium.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05CM19, suvorexant, Opium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Opium can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Opium can be decreased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AA04, acepromazine, The risk or severity of hypotension and CNS depression can be increased when Acepromazine is combined with Opium.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Opium.]
[A06AH03, naloxegol, The risk or severity of adverse effects can be increased when Naloxegol is combined with Opium.]
[N04AA02, biperiden, The risk or severity of adverse effects can be increased when Biperiden is combined with Opium.]
[L04AX05, pirfenidone, The metabolism of Opium can be decreased when combined with Pirfenidone.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Opium.]
[S03AA06, gentamicin, Opium may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[J05AP09, dasabuvir, The metabolism of Opium can be decreased when combined with Dasabuvir.]
[B01AF03, edoxaban, Edoxaban may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AX11, mirtazapine, Opium may increase the serotonergic activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Opium can be increased when combined with Secukinumab.]
[L01XH03, panobinostat, The metabolism of Opium can be decreased when combined with Panobinostat.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Opium which could result in a higher serum level.]
[A03AA09, difemerine, The risk or severity of adverse effects can be increased when Difemerine is combined with Opium.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Opium which could result in a higher serum level.]
[J05AP06, asunaprevir, The metabolism of Opium can be decreased when combined with Asunaprevir.]
[A07DA06, eluxadoline, The risk or severity of constipation can be increased when Opium is combined with Eluxadoline.]
[N05AX16, brexpiprazole, The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Opium.]
[A04AD14, rolapitant, The metabolism of Opium can be decreased when combined with Rolapitant.]
[G02CX02, flibanserin, The risk or severity of adverse effects can be increased when Flibanserin is combined with Opium.]
[A06AD03, magnesium peroxide, The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Opium.]
[N05AX15, cariprazine, The risk or severity of adverse effects can be increased when Cariprazine is combined with Opium.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Opium which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Opium which could result in a higher serum level.]
[S01EC01, acetazolamide, The risk or severity of adverse effects can be increased when Acetazolamide is combined with Opium.]
[N05AB07, acetophenazine, The risk or severity of hypotension and CNS depression can be increased when Acetophenazine is combined with Opium.]
[A02BC03, lansoprazole, The metabolism of Opium can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Idarucizumab may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Opium.]
[J02AC05, isavuconazole, The metabolism of Opium can be decreased when combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Opium.]
[L01XG03, ixazomib, Ixazomib may decrease the excretion rate of Opium which could result in a higher serum level.]
[M04AB05, lesinurad, Opium may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Aprobarbital is combined with Opium.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Opium which could result in a higher serum level.]
[N03AX23, brivaracetam, The risk or severity of adverse effects can be increased when Brivaracetam is combined with Opium.]
[L01XX52, venetoclax, The metabolism of Opium can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Opium is combined with Bromazepam.]
[N04BC01, bromocriptine, The risk or severity of adverse effects can be increased when Bromocriptine is combined with Opium.]
[A02AD05, aluminum magnesium silicate, Opium may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Alverine is combined with Opium.]
[R06AB01, brompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Opium.]
[N06AA19, amineptin, The risk or severity of adverse effects can be increased when Amineptine is combined with Opium.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Aniracetam is combined with Opium.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Opium.]
[C07AA19, bupranolol, The metabolism of Opium can be decreased when combined with Bupranolol.]
[N07BC01, buprenorphine, Opium may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The risk or severity of adverse effects can be increased when Buspirone is combined with Opium.]
[L01XX27, arsenic trioxide, Arsenic trioxide may decrease the excretion rate of Opium which could result in a higher serum level.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02AF01, butorphanol, The therapeutic efficacy of Opium can be decreased when used in combination with Butorphanol.]
[S01GX07, azelastine, Opium may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Opium can be decreased when combined with Rucaparib.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Opium.]
[L01EF02, ribociclib, The metabolism of Opium can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Opium which could result in a higher serum level.]
[A06AH05, naldemedine, The therapeutic efficacy of Opium can be decreased when used in combination with Naldemedine.]
[N07XX16, deutetrabenazine, Opium may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, The therapeutic efficacy of Opium can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Beclamide is combined with Opium.]
[S01HA02, benoxinate, The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Opium.]
[P01CA02, benznidazole, Opium may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Opium.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Opium which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Opium can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, Opium may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Opium can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Opium can be decreased when combined with Midostaurin.]
[N04BD03, safinamide, The risk or severity of adverse effects can be increased when Opium is combined with Safinamide.]
[J01MA23, delafloxacin, Opium may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, Capecitabine may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Opium.]
[C07AB07, bisoprolol, Bisoprolol may decrease the excretion rate of Opium which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Opium can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Opium which could result in a higher serum level.]
[C07AA17, bopindolol, The metabolism of Opium can be decreased when combined with Bopindolol.]
[N04AA11, bornaprine, The risk or severity of adverse effects can be increased when Bornaprine is combined with Opium.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Opium is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Opium is combined with Brotizolam.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Budesonide may decrease the excretion rate of Opium which could result in a higher serum level.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Butobarbital is combined with Opium.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Opium.]
[N06AA15, butriptyline, The risk or severity of adverse effects can be increased when Butriptyline is combined with Opium.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Opium is combined with Vinylbital.]
[R06AX18, acrivastine, Acrivastine may decrease the excretion rate of Opium which could result in a higher serum level.]
[L02BB05, apalutamide, The metabolism of Opium can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Opium can be increased when combined with Carbamazepine.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Opium.]
[A03AA03, camylofine, The risk or severity of adverse effects can be increased when Camylofin is combined with Opium.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Opium.]
[C07AG02, carvedilol, The metabolism of Opium can be decreased when combined with Carvedilol.]
[N03AX24, cannabidiol, The risk or severity of adverse effects can be increased when Cannabidiol is combined with Opium.]
[L04AA37, baricitinib, Opium may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Opium.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01GB14, plazomicin, Opium may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, The metabolism of Opium can be decreased when combined with Celiprolol.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Opium.]
[L01XX62, ivosidenib, The metabolism of Opium can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Opium can be decreased when combined with Tafenoquine.]
[A16AX14, migalastat, Migalastat may decrease the excretion rate of Opium which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Opium can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Opium.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Cetirizine is combined with Opium.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Opium is combined with Carbromal.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Opium.]
[D08AE05, chloroxylenol, Chloroxylenol may decrease the excretion rate of Opium which could result in a higher serum level.]
[R06AA06, chlorphenoxamine, The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Opium.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Opium which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Opium which could result in a higher serum level.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Opium.]
[R03BB08, revefenacin, The risk or severity of adverse effects can be increased when Revefenacin is combined with Opium.]
[L04AA39, emapalumab, The metabolism of Opium can be increased when combined with Emapalumab.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Opium which could result in a higher serum level.]
[A06AX05, prucalopride, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Opium.]
[B01AC23, cilostazol, Cilostazol may decrease the excretion rate of Opium which could result in a higher serum level.]
[A03FA08, cinitapride, The risk or severity of adverse effects can be increased when Cinitapride is combined with Opium.]
[P02BX04, triclabendazole, The metabolism of Opium can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Opium is combined with Esketamine.]
[J01FA09, clarithromycin, The metabolism of Opium can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of adverse effects can be increased when Opium is combined with Solriamfetol.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Opium is combined with Brexanolone.]
[N05BA09, clobazam, The metabolism of Opium can be decreased when combined with Clobazam.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Opium.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Opium is combined with Cloxazolam.]
[L04AB01, etanercept, The metabolism of Opium can be increased when combined with Etanercept.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AA06, cyamemazine, The risk or severity of hypotension and CNS depression can be increased when Cyamemazine is combined with Opium.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Opium which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Opium which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Opium which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Opium.]
[L01EJ02, fedratinib, The metabolism of Opium can be decreased when combined with Fedratinib.]
[N07XX11, pitolisant, The serum concentration of Opium can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Opium.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE04, yohimbine, The risk or severity of adverse effects can be increased when Yohimbine is combined with Opium.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Opium.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02CC08, lasmiditan, The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Opium.]
[N03AX25, cenobamate, The serum concentration of Opium can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Opium can be increased when it is combined with Givosiran.]
[M09AX08, golodirsen, Opium may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Opium.]
[R06AB02, dexchlorpheniramine, The metabolism of Opium can be decreased when combined with Dexchlorpheniramine.]
[S01XA12, dexpanthenol, Dexpanthenol may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Dezocine is combined with Opium.]
[N05CM21, lemborexant, The risk or severity of adverse effects can be increased when Opium is combined with Lemborexant.]
[N05AD10, lumateperone, The risk or severity of adverse effects can be increased when Lumateperone is combined with Opium.]
[M01AX21, diacetylrhein, The metabolism of Opium can be decreased when combined with Diacerein.]
[H02CA02, osilodrostat, The metabolism of Opium can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Opium can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The risk or severity of adverse effects can be increased when Frovatriptan is combined with Opium.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Opium.]
[R02AA03, dichlorobenzyl alcohol, Opium may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Dienogest may decrease the excretion rate of Opium which could result in a higher serum level.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Difenoxin is combined with Opium.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Opium.]
[N02CC06, eletriptan, The risk or severity of adverse effects can be increased when Eletriptan is combined with Opium.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Opium which could result in a higher serum level.]
[C08CA16, clevidipine, Clevidipine may decrease the excretion rate of Opium which could result in a higher serum level.]
[C01BD07, dronedarone, The metabolism of Opium can be decreased when combined with Dronedarone.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Valpromide is combined with Opium.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Opium is combined with Chlordiazepoxide.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Opium.]
[A03AA08, dihexyverine, The risk or severity of adverse effects can be increased when Dihexyverine is combined with Opium.]
[G04BD09, trospium, The risk or severity of adverse effects can be increased when Trospium is combined with Opium.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Opium which could result in a higher serum level.]
[V08CA05, mangafodipir, Mangafodipir may decrease the excretion rate of Opium which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05CM02, chlormethiazole, The risk or severity of adverse effects can be increased when Clomethiazole is combined with Opium.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Chlormezanone is combined with Opium.]
[R02AD04, dyclonine, The risk or severity of adverse effects can be increased when Dyclonine is combined with Opium.]
[P01BB01, proguanil, The metabolism of Opium can be decreased when combined with Proguanil.]
[N05CD14, remimazolam, The risk or severity of adverse effects can be increased when Opium is combined with Remimazolam.]
[L04AC19, satralizumab, The serum concentration of Opium can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Opium is combined with Oliceridine.]
[P01BA01, chloroquine, The metabolism of Opium can be decreased when combined with Chloroquine.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Opium.]
[N05AA01, chlorpromazine, The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Opium.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AF03, chlorprothixene, The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Opium.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Opium.]
[A11CC05, cholecalciferol, The metabolism of Opium can be decreased when combined with Cholecalciferol.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Etifoxine is combined with Opium.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02BA03, choline salicylate, Opium may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[N06BX18, vinpocetine, The risk or severity of adverse effects can be increased when Opium is combined with Vinpocetine.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Opium is combined with Ethyl loflazepate.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Opium which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Opium which could result in a higher serum level.]
[B06AC06, berotralstat, The metabolism of Opium can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Opium can be decreased when combined with Lonafarnib.]
[M01AX25, chondroitin sulfates, Chondroitin sulfate may decrease the excretion rate of Opium which could result in a higher serum level.]
[P03AX07, abametapir, The serum concentration of Opium can be increased when it is combined with Abametapir.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Opium is combined with Febarbamate.]
[N03AX10, felbamate, The risk or severity of adverse effects can be increased when Felbamate is combined with Opium.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Opium which could result in a higher serum level.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Opium which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02BG07, flupirtine, Flupirtine may decrease the excretion rate of Opium which could result in a higher serum level.]
[R03CC15, formoterol, The metabolism of Opium can be decreased when combined with Formoterol.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Opium is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The metabolism of Opium can be decreased when combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The metabolism of Opium can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Gabapentin is combined with Opium.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Opium which could result in a higher serum level.]
[N07CA02, cinnarizine, The metabolism of Opium can be decreased when combined with Cinnarizine.]
[L01XX73, sotorasib, The serum concentration of Opium can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Opium can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, Opium may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The risk or severity of serotonin syndrome can be increased when Opium is combined with Citalopram.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Opium.]
[V09AB03, ioflupane I-123, Ioflupane I-123 may decrease the excretion rate of Opium which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Technetium Tc-99m exametazime may decrease the excretion rate of Opium which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Florbetaben (18F) may decrease the excretion rate of Opium which could result in a higher serum level.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Clemastine is combined with Opium.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AX25, St. John's wort extract, The metabolism of Opium can be increased when combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Opium.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Opium.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Opium.]
[N03AE01, clonazepam, The risk or severity of adverse effects can be increased when Opium is combined with Clonazepam.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Opium.]
[C01EB24, mavacamten, The serum concentration of Opium can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Opium which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Opium is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Opium is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of adverse effects can be increased when Ondansetron is combined with Opium.]
[A04AA02, granisetron, The risk or severity of adverse effects can be increased when Granisetron is combined with Opium.]
[N05AH02, clozapine, The risk or severity of adverse effects can be increased when Clozapine is combined with Opium.]
[J01GB12, arbekacin, Opium may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Opium is combined with Halazepam.]
[H01AC08, somatrogon, The metabolism of Opium can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of adverse effects can be increased when Cocaine is combined with Opium.]
[C02KB01, metyrosine, Opium may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Opium can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Opium which could result in a higher serum level.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Codeine is combined with Opium.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Hexafluronium is combined with Opium.]
[M04AC01, colchicine, Colchicine may decrease the excretion rate of Opium which could result in a higher serum level.]
[A03AB10, hexocyclium, The risk or severity of adverse effects can be increased when Hexocyclium is combined with Opium.]
[A03BB06, homatropine methylbromide, The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Opium.]
[J01XB01, colistin, Opium may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Opium which could result in a higher serum level.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Desflurane is combined with Opium.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Opium is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Ifenprodil is combined with Opium.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01FA15, telithromycin, The metabolism of Opium can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Opium can be decreased when combined with Ciclesonide.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Opium which could result in a higher serum level.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Desloratadine is combined with Opium.]
[J05AB14, valganciclovir, Valganciclovir may decrease the excretion rate of Opium which could result in a higher serum level.]
[C05BB03, invert sugar, Invert sugar may decrease the excretion rate of Opium which could result in a higher serum level.]
[V08AB09, iodixanol, Iodixanol may decrease the excretion rate of Opium which could result in a higher serum level.]
[V08AB05, iopromide, Iopromide may decrease the excretion rate of Opium which could result in a higher serum level.]
[V08AB07, ioversol, Ioversol may decrease the excretion rate of Opium which could result in a higher serum level.]
[V08AB12, ioxilan, Ioxilan may decrease the excretion rate of Opium which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Opium which could result in a higher serum level.]
[H01AX01, pegvisomant, The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Opium.]
[N02CC05, almotriptan, The risk or severity of adverse effects can be increased when Almotriptan is combined with Opium.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Opium which could result in a higher serum level.]
[J02AC02, itraconazole, The metabolism of Opium can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05BA10, ketazolam, The risk or severity of adverse effects can be increased when Opium is combined with Ketazolam.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01EA01, imatinib, The serum concentration of Opium can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Opium can be decreased when combined with Posaconazole.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Opium.]
[N03AX09, lamotrigine, The risk or severity of adverse effects can be increased when Lamotrigine is combined with Opium.]
[N07BC04, lofexidine, The therapeutic efficacy of Opium can be increased when used in combination with Lofexidine.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Opium is combined with Lormetazepam.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Opium which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Opium which could result in a higher serum level.]
[A06AD01, magnesium carbonate, The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Opium.]
[C08CA11, manidipine, The metabolism of Opium can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, The risk or severity of adverse effects can be increased when Mebeverine is combined with Opium.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Opium is combined with Medifoxamine.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Opium.]
[R06AD07, mequitazine, The metabolism of Opium can be decreased when combined with Mequitazine.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Opium which could result in a higher serum level.]
[N04AA03, methixene, The risk or severity of adverse effects can be increased when Metixene is combined with Opium.]
[R03CB02, methoxyphenamine, Methoxyphenamine may increase the analgesic activities of Opium.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Cyclizine is combined with Opium.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Opium is combined with Cyclobarbital.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Melperone is combined with Opium.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AX07, minaprine, The risk or severity of adverse effects can be increased when Opium is combined with Minaprine.]
[S01XA18, cyclosporine, The metabolism of Opium can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The risk or severity of adverse effects can be increased when Opium is combined with Moclobemide.]
[R06AX02, cyproheptadine, The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Opium.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Opium which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Opium which could result in a higher serum level.]
[C03XA02, conivaptan, The metabolism of Opium can be decreased when combined with Conivaptan.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01AX04, dacarbazine, Dacarbazine may decrease the excretion rate of Opium which could result in a higher serum level.]
[G03XA01, danazol, The metabolism of Opium can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Dantrolene is combined with Opium.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Opium is combined with Deanol.]
[C02CC04, debrisoquin, The metabolism of Opium can be decreased when combined with Debrisoquine.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Opium which could result in a higher serum level.]
[N07BB05, nalmefene, The therapeutic efficacy of Opium can be decreased when used in combination with Nalmefene.]
[B05XA15, potassium lactate, The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Opium.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Opium is combined with Nordazepam.]
[C07AB12, nebivolol, The metabolism of Opium can be decreased when combined with Nebivolol.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AX06, nefazodone, The metabolism of Opium can be decreased when combined with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Opium is combined with Niaprazine.]
[C01DX16, nicorandil, Nicorandil may decrease the excretion rate of Opium which could result in a higher serum level.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Opium which could result in a higher serum level.]
[N03AG06, tiagabine, The risk or severity of adverse effects can be increased when Tiagabine is combined with Opium.]
[M03AC11, cisatracurium, The risk or severity of adverse effects can be increased when Cisatracurium is combined with Opium.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Opium is combined with Normethadone.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AB10, escitalopram, The risk or severity of serotonin syndrome can be increased when Opium is combined with Escitalopram.]
[G04BD08, solifenacin, The risk or severity of adverse effects can be increased when Solifenacin is combined with Opium.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AA01, desipramine, The risk or severity of adverse effects can be increased when Desipramine is combined with Opium.]
[H01BA02, desmopressin, The risk or severity of hyponatremia can be increased when Opium is combined with Desmopressin.]
[V04CH02, indigo carmine, Opium may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Opium which could result in a higher serum level.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Opium which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Opium.]
[S03BA01, dexamethasone, The metabolism of Opium can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Opium is combined with Oxiracetam.]
[N04AA08, dexetimide, The risk or severity of adverse effects can be increased when Dexetimide is combined with Opium.]
[G04BD04, oxybutynin, The risk or severity of adverse effects can be increased when Oxybutynin is combined with Opium.]
[A08AA04, dexfenfluramine, The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Opium.]
[A03AA01, oxyphencyclimine, The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Opium.]
[L04AB04, adalimumab, The metabolism of Opium can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Opium can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, Amphetamine may increase the analgesic activities of Opium.]
[R05DA09, dextromethorphan, The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Opium.]
[N03AC01, paramethadione, The risk or severity of adverse effects can be increased when Paramethadione is combined with Opium.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Dextromoramide is combined with Opium.]
[N06AB05, paroxetine, The risk or severity of serotonin syndrome can be increased when Opium is combined with Paroxetine.]
[B01AC04, clopidogrel, Opium can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Diamorphine is combined with Opium.]
[P03AC04, permethrin, Permethrin may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05BA01, diazepam, The risk or severity of adverse effects can be increased when Opium is combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Phenacemide is combined with Opium.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Phensuximide is combined with Opium.]
[N06AA08, dibenzepin, The risk or severity of adverse effects can be increased when Opium is combined with Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of adverse effects can be increased when Cinchocaine is combined with Opium.]
[R05DA08, pholcodine, Pholcodine may decrease the excretion rate of Opium which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Opium which could result in a higher serum level.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Opium which could result in a higher serum level.]
[A03AA07, dicyclomine, The risk or severity of adverse effects can be increased when Dicyclomine is combined with Opium.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Pipamperone is combined with Opium.]
[A03AB14, pipenzolate, The risk or severity of adverse effects can be increased when Pipenzolate is combined with Opium.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Opium.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, Diethylpropion may increase the analgesic activities of Opium.]
[C08CA03, isradipine, The metabolism of Opium can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, Difluocortolone may decrease the excretion rate of Opium which could result in a higher serum level.]
[A03AB11, poldine, The risk or severity of adverse effects can be increased when Poldine is combined with Opium.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Opium which could result in a higher serum level.]
[C01AA05, digoxin, Opium may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[N02CA01, dihydroergotamine, The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Opium.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Hydromorphone is combined with Opium.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Opium which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Opium can be decreased when combined with Atazanavir.]
[H03BC01, potassium perchlorate, Potassium perchlorate may decrease the excretion rate of Opium which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Opium which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of adverse effects can be increased when Pramocaine is combined with Opium.]
[C08DB01, diltiazem, The metabolism of Opium can be decreased when combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Opium.]
[V03AB09, dimercaprol, Dimercaprol may decrease the excretion rate of Opium which could result in a higher serum level.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Opium is combined with Pridinol.]
[R06AB03, dimethindene, The risk or severity of adverse effects can be increased when Dimetindene is combined with Opium.]
[M02AX03, dimethyl sulfoxide, The metabolism of Opium can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Progabide is combined with Opium.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Opium which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Opium which could result in a higher serum level.]
[R06AA02, diphenhydramine, The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Opium.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Opium.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Opium is combined with Quazepam.]
[N06BA11, dexmethylphenidate, The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Opium.]
[N06AA23, quinupramine, The risk or severity of adverse effects can be increased when Opium is combined with Quinupramine.]
[A03FA02, cisapride, The metabolism of Opium can be decreased when combined with Cisapride.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Remoxipride is combined with Opium.]
[S01AX06, resorcinol, Resorcinol may decrease the excretion rate of Opium which could result in a higher serum level.]
[C01BA03, disopyramide, The risk or severity of adverse effects can be increased when Disopyramide is combined with Opium.]
[S02AA12, rifamycin SV, The metabolism of Opium can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Opium can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Riluzole is combined with Opium.]
[N05AX08, risperidone, The risk or severity of adverse effects can be increased when Risperidone is combined with Opium.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Levocetirizine is combined with Opium.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Opium.]
[A04AD12, aprepitant, The metabolism of Opium can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The metabolism of Opium can be decreased when combined with Bortezomib.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Opium which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Opium which could result in a higher serum level.]
[C01EB18, ranolazine, The serum concentration of Opium can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Opium which could result in a higher serum level.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Opium which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Opium which could result in a higher serum level.]
[A03FA03, domperidone, The metabolism of Opium can be decreased when combined with Domperidone.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AA16, dothiepin, The risk or severity of adverse effects can be increased when Dosulepin is combined with Opium.]
[N06AA12, doxepin, The risk or severity of adverse effects can be increased when Doxepin is combined with Opium.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Opium.]
[L01DB01, doxorubicin, The metabolism of Opium can be decreased when combined with Doxorubicin.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Opium which could result in a higher serum level.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[N06AB06, sertraline, The risk or severity of serotonin syndrome can be increased when Opium is combined with Sertraline.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Sevoflurane is combined with Opium.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[A08AA10, sibutramine, The risk or severity of serotonin syndrome can be increased when Opium is combined with Sibutramine.]
[C10AA01, simvastatin, The metabolism of Opium can be decreased when combined with Simvastatin.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Opium.]
[A12CA02, sodium sulfate, The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Opium.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Opium is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of adverse effects can be increased when Sumatriptan is combined with Opium.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Opium which could result in a higher serum level.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Opium.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Opium which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Opium which could result in a higher serum level.]
[D01BA02, terbinafine, The metabolism of Opium can be decreased when combined with Terbinafine.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Opium.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Opium is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Opium is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Opium is combined with Thiopropazate.]
[G04BD01, emepronium, The risk or severity of adverse effects can be increased when Emepronium is combined with Opium.]
[N06AX14, tianeptine, The risk or severity of adverse effects can be increased when Tianeptine is combined with Opium.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Tofisopam is combined with Opium.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AG03, toloxatone, The risk or severity of adverse effects can be increased when Opium is combined with Toloxatone.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N03AX11, topiramate, The risk or severity of adverse effects can be increased when Topiramate is combined with Opium.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Opium is combined with Loprazolam.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Opium.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Triclofos is combined with Opium.]
[A03AB08, tridihexethyl, The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Opium.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Opium.]
[N04AA12, tropatepine, The risk or severity of adverse effects can be increased when Tropatepine is combined with Opium.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Opium.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Opium is combined with Urapidil.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Opium is combined with Veralipride.]
[L01CA04, vinorelbine, The metabolism of Opium can be decreased when combined with Vinorelbine.]
[S01GX10, epinastine, The risk or severity of adverse effects can be increased when Epinastine is combined with Opium.]
[N06AX16, venlafaxine, The risk or severity of serotonin syndrome can be increased when Opium is combined with Venlafaxine.]
[C08CA12, mepirodipine, The metabolism of Opium can be decreased when combined with Barnidipine.]
[N05CF02, zolpidem, Opium may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Opium which could result in a higher serum level.]
[N03AX15, zonisamide, The risk or severity of adverse effects can be increased when Zonisamide is combined with Opium.]
[N05CF01, zopiclone, The risk or severity of adverse effects can be increased when Opium is combined with Zopiclone.]
[N05AX11, zotepine, The risk or severity of adverse effects can be increased when Zotepine is combined with Opium.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Opium which could result in a higher serum level.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Guanfacine is combined with Opium.]
[C01BG01, moricizine, The risk or severity of hypotension and CNS depression can be increased when Moricizine is combined with Opium.]
[G02AB03, ergonovine, The risk or severity of adverse effects can be increased when Ergometrine is combined with Opium.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Opium.]
[N02CA02, ergotamine, The metabolism of Opium can be decreased when combined with Ergotamine.]
[N03AG01, valproic acid, The risk or severity of adverse effects can be increased when Valproic acid is combined with Opium.]
[L03AX05, pidotimod, Opium may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The metabolism of Opium can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, The risk or severity of adverse effects can be increased when Opium is combined with Estazolam.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Opium which could result in a higher serum level.]
[H05BX01, cinacalcet, The metabolism of Opium can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Opium which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Opium which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Opium which could result in a higher serum level.]
[C10AA04, fluvastatin, The metabolism of Opium can be decreased when combined with Fluvastatin.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Opium which could result in a higher serum level.]
[C01CA15, gepefrine, Gepefrine may increase the analgesic activities of Opium.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Opium.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Opium which could result in a higher serum level.]
[N04AA05, profenamine, The risk or severity of adverse effects can be increased when Profenamine is combined with Opium.]
[N03AD01, ethosuximide, The risk or severity of adverse effects can be increased when Ethosuximide is combined with Opium.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Ethotoin is combined with Opium.]
[M01AC06, meloxicam, Meloxicam may decrease the excretion rate of Opium which could result in a higher serum level.]
[S01XA06, ethylmorphine, The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Opium.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Opium.]
[N05AE03, sertindole, The risk or severity of adverse effects can be increased when Sertindole is combined with Opium.]
[L04AD02, tacrolimus, Tacrolimus may decrease the excretion rate of Opium which could result in a higher serum level.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Opium.]
[R06AX12, terfenadine, The metabolism of Opium can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Trimetrexate may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AX12, bupropion, The metabolism of Opium can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The risk or severity of serotonin syndrome can be increased when Opium is combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Opium can be decreased when combined with Encainide.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Opium which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Sodium aurothiomalate may decrease the excretion rate of Opium which could result in a higher serum level.]
[B05AA05, dextran, Dextran may decrease the excretion rate of Opium which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Opium which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Opium which could result in a higher serum level.]
[C08CA02, felodipine, The metabolism of Opium can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The risk or severity of serotonin syndrome can be increased when Opium is combined with Fenfluramine.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Opium which could result in a higher serum level.]
[R03CC04, fenoterol, The risk or severity of adverse effects can be increased when Fenoterol is combined with Opium.]
[N02AB03, fentanyl, The risk or severity of adverse effects can be increased when Fentanyl is combined with Opium.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01BB06, clofarabine, Clofarabine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04BD02, flavoxate, The risk or severity of adverse effects can be increased when Flavoxate is combined with Opium.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Opium.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Opium which could result in a higher serum level.]
[J02AC01, fluconazole, The metabolism of Opium can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, Flucytosine may decrease the excretion rate of Opium which could result in a higher serum level.]
[V03AB25, flumazenil, Flumazenil may decrease the excretion rate of Opium which could result in a higher serum level.]
[N07CA03, flunarizine, The risk or severity of adverse effects can be increased when Flunarizine is combined with Opium.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Opium is combined with Flunitrazepam.]
[N06AA14, melitracen, The risk or severity of adverse effects can be increased when Opium is combined with Melitracen.]
[V03AZ01, ethanol, Opium may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AB03, fluoxetine, The serum concentration of Opium can be increased when it is combined with Fluoxetine.]
[N05AF01, flupenthixol, Opium may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Opium.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Opium is combined with Flurazepam.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AG01, fluspirilene, The risk or severity of adverse effects can be increased when Fluspirilene is combined with Opium.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Opium which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Opium which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Opium which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01BC03, tegafur, Tegafur may decrease the excretion rate of Opium which could result in a higher serum level.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Alcuronium is combined with Opium.]
[G01AX06, furazolidone, The risk or severity of adverse effects can be increased when Opium is combined with Furazolidone.]
[J05AE10, darunavir, The metabolism of Opium can be decreased when combined with Darunavir.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Opium is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Amisulpride is combined with Opium.]
[N06DA04, galantamine, The metabolism of Opium can be decreased when combined with Galantamine.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Gallamine is combined with Opium.]
[S01AD09, ganciclovir, Ganciclovir may decrease the excretion rate of Opium which could result in a higher serum level.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Barbexaclone is combined with Opium.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Opium is combined with Bifemelane.]
[C10AB04, gemfibrozil, Gemfibrozil may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01XA03, telavancin, Telavancin may decrease the excretion rate of Opium which could result in a higher serum level.]
[N04BC06, cabergoline, The risk or severity of adverse effects can be increased when Cabergoline is combined with Opium.]
[N03AD03, methsuximide, The risk or severity of adverse effects can be increased when Methsuximide is combined with Opium.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Alfentanil is combined with Opium.]
[A06AH02, alvimopan, The risk or severity of adverse effects can be increased when Opium is combined with Alvimopan.]
[A10BB07, glipizide, Glipizide may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Opium.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Glutethimide is combined with Opium.]
[A06AX01, glycerin, The therapeutic efficacy of Glycerin can be decreased when used in combination with Opium.]
[C02CA04, doxazosin, The metabolism of Opium can be decreased when combined with Doxazosin.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Opium which could result in a higher serum level.]
[C07AB09, esmolol, The metabolism of Opium can be decreased when combined with Esmolol.]
[M01CB04, aurothioglucose, Aurothioglucose may decrease the excretion rate of Opium which could result in a higher serum level.]
[S01LA03, pegaptanib, Pegaptanib may decrease the excretion rate of Opium which could result in a higher serum level.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Opium which could result in a higher serum level.]
[S01EX01, guanethidine, Guanethidine may decrease the excretion rate of Opium which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Opium which could result in a higher serum level.]
[P01BX01, halofantrine, The metabolism of Opium can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Opium.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Halothane is combined with Opium.]
[N05AH04, quetiapine, The risk or severity of adverse effects can be increased when Quetiapine is combined with Opium.]
[N06BX13, idebenone, Idebenone may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Opium is combined with Iprazochrome.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Opium is combined with Allobarbital.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Opium which could result in a higher serum level.]
[B05CB03, magnesium citrate, The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Opium.]
[G03DC01, allylestrenol, Allylestrenol may decrease the excretion rate of Opium which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Opium which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Opium which could result in a higher serum level.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Opium.]
[N05CA16, hexobarbital, The risk or severity of adverse effects can be increased when Hexobarbital is combined with Opium.]
[J05AG01, nevirapine, The metabolism of Opium can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Opium can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, Nimesulide may decrease the excretion rate of Opium which could result in a higher serum level.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Opium which could result in a higher serum level.]
[C02DB02, hydralazine, Hydralazine may decrease the excretion rate of Opium which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA03, hydrocodone, Opium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Opium may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04BD06, propiverine, The risk or severity of adverse effects can be increased when Propiverine is combined with Opium.]
[P01BA02, hydroxychloroquine, The metabolism of Opium can be decreased when combined with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Opium is combined with Prothipendyl.]
[B05AA07, hetastarch, Hydroxyethyl Starch may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Opium which could result in a higher serum level.]
[B05XA08, sodium acetate, Sodium acetate may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01DB06, idarubicin, The metabolism of Opium can be decreased when combined with Idarubicin.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Opium.]
[L01AA06, ifosfamide, Ifosfamide may decrease the excretion rate of Opium which could result in a higher serum level.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Sufentanil is combined with Opium.]
[N06AA02, imipramine, The risk or severity of adverse effects can be increased when Imipramine is combined with Opium.]
[R01AD07, tixocortol, Tixocortol may decrease the excretion rate of Opium which could result in a higher serum level.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Tizanidine is combined with Opium.]
[L01CE01, topotecan, Topotecan may decrease the excretion rate of Opium which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Opium which could result in a higher serum level.]
[A11HA07, inositol, Opium may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, The risk or severity of serotonin syndrome can be increased when Opium is combined with Milnacipran.]
[A03AA30, piperidolate, The risk or severity of adverse effects can be increased when Piperidolate is combined with Opium.]
[S01XA28, varenicline, Varenicline may decrease the excretion rate of Opium which could result in a higher serum level.]
[N01BB08, articaine, The risk or severity of adverse effects can be increased when Articaine is combined with Opium.]
[A10BH01, sitagliptin, Sitagliptin may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05BA12, alprazolam, The risk or severity of adverse effects can be increased when Opium is combined with Alprazolam.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Ramelteon is combined with Opium.]
[R06AE01, buclizine, The risk or severity of adverse effects can be increased when Buclizine is combined with Opium.]
[C10AA06, cerivastatin, The metabolism of Opium can be decreased when combined with Cerivastatin.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Alprenolol is combined with Opium.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Opium may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AA13, iprindole, The risk or severity of adverse effects can be increased when Opium is combined with Iprindole.]
[N06AF05, iproniazid, The risk or severity of adverse effects can be increased when Opium is combined with Iproniazid.]
[N05AA07, chlorproethazine, The risk or severity of hypotension and CNS depression can be increased when Chlorproethazine is combined with Opium.]
[N06AF01, isocarboxazid, The risk or severity of adverse effects can be increased when Opium is combined with Isocarboxazid.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Opium.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Entacapone is combined with Opium.]
[J04AC01, isoniazid, The metabolism of Opium can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Opium may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Opium which could result in a higher serum level.]
[D10BA01, isotretinoin, Isotretinoin may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Opium.]
[S01AA24, kanamycin, Opium may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Opium can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The risk or severity of adverse effects can be increased when Ketamine is combined with Opium.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Opium is combined with Ketanserin.]
[B01AC22, prasugrel, Prasugrel may decrease the excretion rate of Opium which could result in a higher serum level.]
[J02AB02, ketoconazole, The metabolism of Opium can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Opium can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Olanzapine is combined with Opium.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Opium which could result in a higher serum level.]
[L04AA24, abatacept, The metabolism of Opium can be increased when combined with Abatacept.]
[N04BC09, rotigotine, Opium may increase the sedative activities of Rotigotine.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Opium which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Opium which could result in a higher serum level.]
[C07AG01, labetalol, The metabolism of Opium can be decreased when combined with Labetalol.]
[N04BB01, amantadine, The risk or severity of adverse effects can be increased when Amantadine is combined with Opium.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Opium.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Opium.]
[N03AX18, lacosamide, The risk or severity of adverse effects can be increased when Lacosamide is combined with Opium.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BA01, levodopa, The risk or severity of adverse effects can be increased when Levodopa is combined with Opium.]
[S02DA01, lidocaine, The risk or severity of adverse effects can be increased when Lidocaine is combined with Opium.]
[S01AA21, amikacin, Opium may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, The risk or severity of adverse effects can be increased when Lisuride is combined with Opium.]
[N06AA07, lofepramine, The risk or severity of adverse effects can be increased when Opium is combined with Lofepramine.]
[N05BA06, lorazepam, The risk or severity of adverse effects can be increased when Opium is combined with Lorazepam.]
[C10AA02, lovastatin, The metabolism of Opium can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The risk or severity of adverse effects can be increased when Loxapine is combined with Opium.]
[L01EG01, temsirolimus, The metabolism of Opium can be decreased when combined with Temsirolimus.]
[B05XA11, magnesium chloride, Magnesium chloride may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, The therapeutic efficacy of Magnesium hydroxide can be decreased when used in combination with Opium.]
[A12CC10, magnesium oxide, The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Opium.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Opium can be increased when used in combination with Magnesium sulfate.]
[L01BA05, pralatrexate, Pralatrexate may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Opium can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, The risk or severity of adverse effects can be increased when Maprotiline is combined with Opium.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Mazindol is combined with Opium.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Mecamylamine is combined with Opium.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Meclizine is combined with Opium.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Opium is combined with Medazepam.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Opium.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Melatonin is combined with Opium.]
[N06DX01, memantine, Memantine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02AB02, meperidine, The risk or severity of adverse effects can be increased when Meperidine is combined with Opium.]
[C01CA11, mephentermine, Mephentermine may increase the analgesic activities of Opium.]
[N03AB04, mephenytoin, The risk or severity of adverse effects can be increased when Mephenytoin is combined with Opium.]
[N03AA01, mephobarbital, The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Opium.]
[N01BB03, mepivacaine, The risk or severity of adverse effects can be increased when Mepivacaine is combined with Opium.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Meprobamate is combined with Opium.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Opium is combined with Meptazinol.]
[G04BX16, tiopronin, Tiopronin may decrease the excretion rate of Opium which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AC03, mesoridazine, The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Opium.]
[N05AX13, paliperidone, The risk or severity of adverse effects can be increased when Paliperidone is combined with Opium.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Opium which could result in a higher serum level.]
[A04AA04, dolasetron, The risk or severity of adverse effects can be increased when Dolasetron is combined with Opium.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Opium.]
[N06BA03, methamphetamine, Metamfetamine may increase the analgesic activities of Opium.]
[A03AB07, methantheline, The risk or severity of adverse effects can be increased when Methantheline is combined with Opium.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Methapyrilene is combined with Opium.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Methaqualone is combined with Opium.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Metharbital is combined with Opium.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Opium is combined with Metergoline.]
[H03BB02, methimazole, The metabolism of Opium can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Opium may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Methocarbamol is combined with Opium.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Methohexital is combined with Opium.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02BG08, ziconotide, The risk or severity of adverse effects can be increased when Ziconotide is combined with Opium.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AA02, methotrimeprazine, Opium may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Opium.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Opium.]
[C02AB01, methyldopa, Methyldopa may decrease the excretion rate of Opium which could result in a higher serum level.]
[V04CG05, methylene blue, Opium may increase the serotonergic activities of Methylene blue.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Opium.]
[G03EK01, methyltestosterone, Methyltestosterone may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Methyprylon is combined with Opium.]
[N02CA04, methysergide, The risk or severity of adverse effects can be increased when Methysergide is combined with Opium.]
[A03FA01, metoclopramide, The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Opium.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, The metabolism of Opium can be decreased when combined with Metoprolol.]
[V04CD01, metyrapone, Metyrapone may decrease the excretion rate of Opium which could result in a higher serum level.]
[C01BB02, mexiletine, The metabolism of Opium can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The risk or severity of adverse effects can be increased when Mianserin is combined with Opium.]
[S02AA13, miconazole, The metabolism of Opium can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05CD08, midazolam, The risk or severity of adverse effects can be increased when Opium is combined with Midazolam.]
[G03XB01, mifepristone, The metabolism of Opium can be decreased when combined with Mifepristone.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Opium.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[L01XX23, mitotane, The metabolism of Opium can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, Lisdexamfetamine may increase the analgesic activities of Opium.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Molindone is combined with Opium.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Opium which could result in a higher serum level.]
[C01BD01, amiodarone, The metabolism of Opium can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The risk or severity of adverse effects can be increased when Amitriptyline is combined with Opium.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Opium.]
[A04AA05, palonosetron, The risk or severity of adverse effects can be increased when Palonosetron is combined with Opium.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Opium which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Opium can be increased when combined with Certolizumab pegol.]
[G04BA01, ammonium chloride, Ammonium chloride may decrease the excretion rate of Opium which could result in a higher serum level.]
[L01EX03, pazopanib, The metabolism of Opium can be decreased when combined with Pazopanib.]
[L04AA06, mycophenolic acid, Mycophenolic acid may decrease the excretion rate of Opium which could result in a higher serum level.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Vecuronium is combined with Opium.]
[N05CA02, amobarbital, The risk or severity of adverse effects can be increased when Amobarbital is combined with Opium.]
[R03BB01, ipratropium bromide, The risk or severity of adverse effects can be increased when Ipratropium is combined with Opium.]
[N06AA17, amoxapine, The risk or severity of adverse effects can be increased when Amoxapine is combined with Opium.]
[N03AB05, fosphenytoin, The metabolism of Opium can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, Nadolol may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01CA04, amoxicillin, Amoxicillin may decrease the excretion rate of Opium which could result in a higher serum level.]
[N04BC04, ropinirole, Opium may increase the sedative activities of Ropinirole.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Opium is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The therapeutic efficacy of Opium can be decreased when used in combination with Nalbuphine.]
[V03AB15, naloxone, The metabolism of Opium can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of adverse effects can be increased when Naltrexone is combined with Opium.]
[L04AC03, anakinra, The metabolism of Opium can be increased when combined with Anakinra.]
[S01GA01, naphazoline, Naphazoline may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[N06BA01, amphetamine, Amphetamine may increase the analgesic activities of Opium.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AX21, duloxetine, The risk or severity of serotonin syndrome can be increased when Opium is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Opium.]
[S03AA01, neomycin, Opium may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Remifentanil is combined with Opium.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AX14, iloperidone, The risk or severity of adverse effects can be increased when Iloperidone is combined with Opium.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Opium which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Opium which could result in a higher serum level.]
[L03AX16, plerixafor, Plerixafor may decrease the excretion rate of Opium which could result in a higher serum level.]
[S01AA23, netilmicin, Opium may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The risk or severity of serotonin syndrome can be increased when Opium is combined with Desvenlafaxine.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Opium which could result in a higher serum level.]
[C01CE01, inamrinone, Amrinone may decrease the excretion rate of Opium which could result in a higher serum level.]
[C10AD02, niacin, The metabolism of Opium can be decreased when combined with Niacin.]
[N06AF02, nialamide, The risk or severity of adverse effects can be increased when Opium is combined with Nialamide.]
[C08CA04, nicardipine, The risk or severity of adverse effects can be increased when Nicardipine is combined with Opium.]
[C04AE02, nicergoline, The metabolism of Opium can be decreased when combined with Nicergoline.]
[C08CA05, nifedipine, Nifedipine may decrease the excretion rate of Opium which could result in a higher serum level.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Opium which could result in a higher serum level.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05CD02, nitrazepam, The risk or severity of adverse effects can be increased when Opium is combined with Nitrazepam.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05CF03, zaleplon, The risk or severity of adverse effects can be increased when Zaleplon is combined with Opium.]
[N04BC05, pramipexole, Opium may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Opium which could result in a higher serum level.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Opium.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Nomifensine is combined with Opium.]
[N06AA10, nortriptyline, The risk or severity of adverse effects can be increased when Nortriptyline is combined with Opium.]
[L04AC04, rilonacept, The metabolism of Opium can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Opium can be decreased when combined with Omeprazole.]
[N06AA05, opipramol, The risk or severity of adverse effects can be increased when Opium is combined with Opipramol.]
[N07XX04, sodium oxybate, Opium may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[C01DA05, pentaerythritol tetranitrate, Pentaerythritol tetranitrate may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Opium which could result in a higher serum level.]
[P02BA02, oxamniquine, The metabolism of Opium can be decreased when combined with Oxamniquine.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Opium is combined with Oxazepam.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Oxprenolol is combined with Opium.]
[N02AA05, oxycodone, The risk or severity of adverse effects can be increased when Oxycodone is combined with Opium.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Oxymorphone is combined with Opium.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Opium is combined with Oxypertine.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Opium which could result in a higher serum level.]
[A03AB03, oxyphenonium, The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Opium.]
[N05AH05, asenapine, The risk or severity of adverse effects can be increased when Asenapine is combined with Opium.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[M03AC01, pancuronium, The risk or severity of adverse effects can be increased when Pancuronium is combined with Opium.]
[J04AB30, capreomycin, Opium may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[N05CC05, paraldehyde, Opium may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[C02KC01, pargyline, The risk or severity of adverse effects can be increased when Opium is combined with Pargyline.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04BD11, fesoterodine, The risk or severity of adverse effects can be increased when Fesoterodine is combined with Opium.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Penbutolol is combined with Opium.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Opium is combined with Penfluridol.]
[J01CE09, penicillin G procaine, Procaine benzylpenicillin may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02AD01, pentazocine, The therapeutic efficacy of Opium can be decreased when used in combination with Pentazocine.]
[N05CA01, pentobarbital, The risk or severity of adverse effects can be increased when Pentobarbital is combined with Opium.]
[L01XX08, pentostatin, Opium may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AB10, perazine, The risk or severity of hypotension and CNS depression can be increased when Perazine is combined with Opium.]
[N04BC02, pergolide, The risk or severity of adverse effects can be increased when Pergolide is combined with Opium.]
[C08EX02, perhexiline, The metabolism of Opium can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Opium.]
[N02BE03, phenacetin, The metabolism of Opium can be decreased when combined with Phenacetin.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Opium is combined with Phenazocine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AF03, phenelzine, The risk or severity of adverse effects can be increased when Opium is combined with Phenelzine.]
[A10BA01, phenformin, The metabolism of Opium can be decreased when combined with Phenformin.]
[N03AA02, phenobarbital, The risk or severity of adverse effects can be increased when Phenobarbital is combined with Opium.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Opium.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Opium is combined with Phenoperidine.]
[A08AA01, phentermine, Phentermine may increase the analgesic activities of Opium.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Opium which could result in a higher serum level.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Opium which could result in a higher serum level.]
[N03AB02, phenytoin, The metabolism of Opium can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Opium can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Levofloxacin may decrease the excretion rate of Opium which could result in a higher serum level.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Opium which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Opium which could result in a higher serum level.]
[C08CX01, mibefradil, The metabolism of Opium can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Opium.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Pindolol is combined with Opium.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Opium which could result in a higher serum level.]
[J05AE01, saquinavir, The metabolism of Opium can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Opium can be decreased when combined with Piperazine.]
[N05AC04, pipothiazine, The risk or severity of hypotension and CNS depression can be increased when Pipotiazine is combined with Opium.]
[N06BX03, piracetam, Piracetam may decrease the excretion rate of Opium which could result in a higher serum level.]
[A02BX03, pirenzepine, The risk or severity of adverse effects can be increased when Pirenzepine is combined with Opium.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Opium is combined with Piritramide.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Opium which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02CX01, pizotyline, The risk or severity of adverse effects can be increased when Pizotifen is combined with Opium.]
[J05AG02, delavirdine, The metabolism of Opium can be decreased when combined with Delavirdine.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Opium is combined with Proxibarbal.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Opium which could result in a higher serum level.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Opium.]
[A03AE01, alosetron, The risk or severity of adverse effects can be increased when Alosetron is combined with Opium.]
[L04AC08, canakinumab, The metabolism of Opium can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The serum concentration of Opium can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, Saxagliptin may decrease the excretion rate of Opium which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Opium which could result in a higher serum level.]
[C07AB01, practolol, The metabolism of Opium can be decreased when combined with Practolol.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Opium is combined with Prazepam.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Opium which could result in a higher serum level.]
[N01BB04, prilocaine, The risk or severity of adverse effects can be increased when Prilocaine is combined with Opium.]
[P01BA03, primaquine, The metabolism of Opium can be decreased when combined with Primaquine.]
[N03AA03, primidone, The risk or severity of adverse effects can be increased when Primidone is combined with Opium.]
[M04AB01, probenecid, Probenecid may decrease the excretion rate of Opium which could result in a higher serum level.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Opium.]
[S01HA05, procaine, The risk or severity of adverse effects can be increased when Opium is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Opium is combined with Procarbazine.]
[C10AB05, fenofibrate, Fenofibrate may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05AB04, prochlorperazine, The risk or severity of hypotension and CNS depression can be increased when Prochlorperazine is combined with Opium.]
[N04AA04, procyclidine, The risk or severity of adverse effects can be increased when Procyclidine is combined with Opium.]
[G03DA04, progesterone, The metabolism of Opium can be decreased when combined with Progesterone.]
[N05AA03, promazine, The risk or severity of adverse effects can be increased when Promazine is combined with Opium.]
[R06AD02, promethazine, The risk or severity of adverse effects can be increased when Promethazine is combined with Opium.]
[C01BC03, propafenone, The metabolism of Opium can be decreased when combined with Propafenone.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Opium is combined with Propanidid.]
[A03AB05, propantheline, The risk or severity of adverse effects can be increased when Propantheline is combined with Opium.]
[N05AC01, periciazine, The risk or severity of hypotension and CNS depression can be increased when Periciazine is combined with Opium.]
[N05CM06, propiomazine, The risk or severity of adverse effects can be increased when Propiomazine is combined with Opium.]
[N01AX10, propofol, The risk or severity of adverse effects can be increased when Propofol is combined with Opium.]
[N02AC04, propoxyphene, The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Opium.]
[C07AA05, propranolol, Propranolol may decrease the excretion rate of Opium which could result in a higher serum level.]
[N02CC04, rizatriptan, The risk or severity of adverse effects can be increased when Rizatriptan is combined with Opium.]
[B01AC09, epoprostenol, Epoprostenol may decrease the excretion rate of Opium which could result in a higher serum level.]
[N06AA11, protriptyline, The risk or severity of adverse effects can be increased when Protriptyline is combined with Opium.]
[R01BA02, pseudoephedrine, Pseudoephedrine may increase the analgesic activities of Opium.]
[N05AX12, aripiprazole, The risk or severity of adverse effects can be increased when Aripiprazole is combined with Opium.]
[N07XX07, dalfampridine, Dalfampridine may decrease the excretion rate of Opium which could result in a higher serum level.]
[A03AB15, diphemanil, The risk or severity of adverse effects can be increased when Diphemanil is combined with Opium.]
[A03AB09, isopropamide, The risk or severity of adverse effects can be increased when Isopropamide is combined with Opium.]
[S01FA03, methscopolamine, The risk or severity of adverse effects can be increased when Methscopolamine is combined with Opium.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Opium.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Opium is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Captodiame is combined with Opium.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Opium is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Opium is combined with Pyrantel.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Opium which could result in a higher serum level.]
[R06AC01, pyrilamine, The risk or severity of adverse effects can be increased when Mepyramine is combined with Opium.]
[C01BA01, quinidine, The risk or severity of adverse effects can be increased when Quinidine is combined with Opium.]
[P01BC01, quinine, The metabolism of Opium can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Opium can be decreased when combined with Ranitidine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Opium.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Opium which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Opium can be increased when combined with Rifampicin.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Oxitriptan is combined with Opium.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Opium which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Opium which could result in a higher serum level.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Opium which could result in a higher serum level.]
[N05CA06, secobarbital, The risk or severity of adverse effects can be increased when Secobarbital is combined with Opium.]
[N04BD01, selegiline, The risk or severity of adverse effects can be increased when Opium is combined with Selegiline.]
[J01GB08, sisomicin, Opium may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Sodium fluoride may decrease the excretion rate of Opium which could result in a higher serum level.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Opium.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Opium.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
